EUVIMEDEUVIMED entdecken
Crossref

Serum tryptophan and kynurenine levels and risk of heart failure among patients with chronic kidney disease

Sara Mohiti, Jacob Christensen, Nino E Landler, Ida Mh Sørensen, Jesper Qvist Thomassen, Sasha S Bjergfelt, Ditte Hansen, Bo Feldt-Rasmussen, Susanne Bro, Mehrangiz Ebrahimi-Mameghani, Tor Biering-Sørensen, Line S Bisgaard und 1 weitere

Clinical Nutrition · 2025

DOI: 10.1016/j.clnu.2025.01.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Sara Mohiti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Student Research Committee, School of Nutr…. Hauptthemen laut MEDLINE: Kynurenine, Tryptophan, Heart Failure, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Augustinus Foundation, Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Chronic kidney disease (CKD) is often complicated by heart failure (HF), leading to increased mortality. Emerging evidence suggests that Tryptophan metabolites, through the Kynurenine pathway (KP), play a significant role in HF pathophysiology. Therefore, we explored the association of Tryptophan (TRP), Kynurenine (KYN), and the Kynurenine to Tryptophan ratio (KTR) with HF in CKD, hypothesizing a link between KP alterations and HF occurrence in this population. METHODS: 673 non-dialysis patients aged 30 to 75 with CKD stages 1-5 were included. Incident HF data were collected through medical record reviews, and the median follow-up time was 3.9 years. Serum concentrations of KYN and TRP were measured using High-Performance Liquid Chromatography (HPLC). RESULTS: Patients with more advanced stages of CKD had higher levels of KYN and KTR, and lower levels of TRP (p < 0.001). Following adjustments for age, sex, BMI, hypertension, and hypercholesterolemia, serum KYN and KTR remained significantly associated with prevalent HF in patients with CKD (p = 0.012, p = 0.028 respectively). Furthermore, Cox-regression analysis indicated that KTR concentration was associated with incident HF after adjusting for confounders such as age, sex, BMI, hypertension, hypercholesterolemia and diabetes (p = 0.019). CONCLUSION: In conclusion, the present analysis suggests that changes in the kynurenine pathway may be a new biomarker for HF in patients with CKD. Thus, KTR concentration might be associated with prevalent and future HF in patients with CKD. Further research is needed to understand the mechanisms and potential of these metabolites in refining HF risk prediction and prevention in CKD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KynurenineTryptophanHeart FailureRenal Insufficiency, ChronicHumansMaleFemaleMiddle AgedAgedAdultRisk FactorsBiomarkers

Stichwörter der Autor:innen

Chronic kidney diseaseHeart failureKynurenineTryptophan

Substanzen

KynurenineTryptophanBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Student Research Committee, School of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz,…
  • Center for Translational Cardiology and Pragmatic Randomized Trials (CTCPR), Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark; Cardiovascular Non-Invasive Imag…
  • Department of Nephrology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Denmark.
  • Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Department of Nephrology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, Denmark.
  • Department of Nephrology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.

Förderung

  • Augustinus Foundation
  • Novo Nordisk Foundation

Zitieren

APA

Mohiti, S., Christensen, J., Landler, N. E., Sørensen, I. M., Thomassen, J. Q., Bjergfelt, S. S., Hansen, D., Feldt-Rasmussen, B., Bro, S., Ebrahimi-Mameghani, M., Biering-Sørensen, T., Bisgaard, L. S., & Christoffersen, C. (2025). Serum tryptophan and kynurenine levels and risk of heart failure among patients with chronic kidney disease. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.01.028

Vancouver

Mohiti S, Christensen J, Landler NE, Sørensen IM, Thomassen JQ, Bjergfelt SS, et al. Serum tryptophan and kynurenine levels and risk of heart failure among patients with chronic kidney disease. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2025.01.028

BibTeX
@article{Mohiti2025,
  author = {Mohiti, Sara and Christensen, Jacob and Landler, Nino E and Sørensen, Ida Mh and Thomassen, Jesper Qvist and Bjergfelt, Sasha S and Hansen, Ditte and Feldt-Rasmussen, Bo and Bro, Susanne and Ebrahimi-Mameghani, Mehrangiz and Biering-Sørensen, Tor and Bisgaard, Line S and Christoffersen, Christina},
  title = {Serum tryptophan and kynurenine levels and risk of heart failure among patients with chronic kidney disease},
  journal = {Clinical Nutrition},
  year = {2025},
  doi = {10.1016/j.clnu.2025.01.028}
}
Kostenlos starten →